EVOMELA is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Cenexi - Bla. The primary component is Melphalan Hydrochloride.
Product ID | 69605-001_d44fac6f-e1e1-399d-e053-2a95a90a81f1 |
NDC | 69605-001 |
Product Type | Human Prescription Drug |
Proprietary Name | EVOMELA |
Generic Name | Melphalan |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2016-03-31 |
Marketing Category | NDA / |
Application Number | NDA207155 |
Labeler Name | CENEXI - BLA |
Substance Name | MELPHALAN HYDROCHLORIDE |
Active Ingredient Strength | 50 mg/10mL |
Pharm Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2016-03-31 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
68152-109 | EVOMELA | Melphalan |
69605-001 | EVOMELA | Melphalan |
72893-001 | EVOMELA | Melphalan |
52609-0001 | ALKERAN | melphalan |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
EVOMELA 86508057 4994159 Live/Registered |
ACROTECH BIOPHARMA LLC 2015-01-20 |